Yarlagadda Babu - BioCryst Pharmaceuticals Insider

BCRX -- USA Stock  

USD 5.97  0.20  3.47%

Sr. VP of Drug Discovery

Dr. Yarlagadda S. Babu, Ph.D., serves as a Senior Vice President Drug Discovery of the company. Dr. Babu was the Vice President Drug Discovery of Biocryst Pharmaceuticals Inc. He joined BioCryst in 1988 and was BioCrysts first fulltime employee
Age: 63  SVP Since 2013      
919-859-1302  http://www.biocryst.com
Babu has served as the Company?s Vice President ? Drug Discovery since 1992. Prior to joining BioCryst, he served five years on the biochemistry faculty at the University of Alabama at Birmingham.

Yarlagadda Babu Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (26.77) % which means that it has lost $26.77 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (154.16) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 54.72 M in liabilities with Debt to Equity (D/E) ratio of 65.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioCryst Pharmaceuticals has Current Ratio of 1.65 which is within standard range for the sector.

Similar Executives

Found 3 records

SVP Since

Judy JoiceDURECT Corporation
Reed ClarkDimension Therapeutics
Bob BrownDicerna Pharmaceuticals

Entity Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. BioCryst Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ. It employs 85 people.BioCryst Pharmaceuticals (BCRX) is traded on NASDAQ in USA. It is located in NORTH CAROLINA, U.S.A and employs 85 people. BioCryst Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

BioCryst Pharmaceuticals Leadership Team

Rob Bennett, President
Alane Barnes, VP
Yarlagadda Babu, SVP
Fred Cohen, Director, Ph.D
Stanley Erck, Director
George Abercrombie, Chairman
Robert Ingram, Director
Thomas Staab, President
Charles Sanders, Director
Jon Stonehouse, CEO
Lynne Powell, President
Sanj Patel, Director
Kenneth Lee, Director
William Sheridan, President, Ph.D
Nancy Hutson, Director

Stock Performance Indicators

Did you try this?

Run Piotroski F Score Now

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Piotroski F Score

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for BioCryst Pharmaceuticals and NantKwest. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.